Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Quantitative risk assessment on the dietary exposure of Finnish children and adults to nitrite.

Suomi J, Ranta J, Tuominen P, Putkonen T, Bäckman C, Ovaskainen ML, Virtanen SM, Savela K.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2016;33(1):41-53. doi: 10.1080/19440049.2015.1117145. Epub 2015 Dec 3.

PMID:
26609554
2.

Intake of selected bioactive compounds from plant food supplements containing fennel (Foeniculum vulgare) among Finnish consumers.

Uusitalo L, Salmenhaara M, Isoniemi M, Garcia-Alvarez A, Serra-Majem L, Ribas-Barba L, Finglas P, Plumb J, Tuominen P, Savela K; PlantLIBRA Project’s Plant Food Supplement Consumer Survey; ePlantLIBRA Database.

Food Chem. 2016 Mar 1;194:619-25. doi: 10.1016/j.foodchem.2015.08.057. Epub 2015 Aug 20.

PMID:
26471600
3.

Urinary adiponectin is an independent predictor of progression to end-stage renal disease in patients with type 1 diabetes and diabetic nephropathy.

Panduru NM, Saraheimo M, Forsblom C, Thorn LM, Gordin D, Wadén J, Tolonen N, Bierhaus A, Humpert PM, Groop PH; FinnDiane Study Group.

Diabetes Care. 2015 May;38(5):883-90. doi: 10.2337/dc14-2276. Epub 2015 Feb 26.

PMID:
25720601
4.

Incidence of stroke according to presence of diabetic nephropathy and severe diabetic retinopathy in patients with type 1 diabetes.

Hägg S, Thorn LM, Putaala J, Liebkind R, Harjutsalo V, Forsblom CM, Gordin D, Tatlisumak T, Groop PH; FinnDiane Study Group.

Diabetes Care. 2013 Dec;36(12):4140-6. doi: 10.2337/dc13-0669. Epub 2013 Oct 7.

5.

Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes.

Sandholm N, McKnight AJ, Salem RM, Brennan EP, Forsblom C, Harjutsalo V, Mäkinen VP, McKay GJ, Sadlier DM, Williams WW, Martin F, Panduru NM, Tarnow L, Tuomilehto J, Tryggvason K, Zerbini G, Comeau ME, Langefeld CD; FIND Consortium, Godson C, Hirschhorn JN, Maxwell AP, Florez JC, Groop PH; FinnDiane Study Group and the GENIE Consortium.

J Am Soc Nephrol. 2013 Oct;24(10):1537-43. doi: 10.1681/ASN.2012111122. Epub 2013 Sep 12.

6.

Patients with Type 1 diabetes consuming alcoholic spirits have an increased risk of microvascular complications.

Harjutsalo V, Feodoroff M, Forsblom C, Groop PH; FinnDiane Study Group.

Diabet Med. 2014 Feb;31(2):156-64. doi: 10.1111/dme.12307. Epub 2013 Sep 14.

PMID:
23952587
7.

Associations and interactions between lipid profiles, retinopathy and nephropathy in patients with type 1 diabetes: the FinnDiane Study.

Tolonen N, Hietala K, Forsblom C, Harjutsalo V, Mäkinen VP, Kytö J, Summanen PA, Thorn LM, Wadén J, Gordin D, Taskinen MR, Groop PH; FinnDiane Study Group.

J Intern Med. 2013 Nov;274(5):469-79. doi: 10.1111/joim.12111. Epub 2013 Aug 1.

8.

Urinary liver-type fatty acid-binding protein and progression of diabetic nephropathy in type 1 diabetes.

Panduru NM, Forsblom C, Saraheimo M, Thorn L, Bierhaus A, Humpert PM, Groop PH; FinnDiane Study Group.

Diabetes Care. 2013 Jul;36(7):2077-83. doi: 10.2337/dc12-1868. Epub 2013 Feb 1.

9.

Cardiorenal end points in a trial of aliskiren for type 2 diabetes.

Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Persson F, Desai AS, Nicolaides M, Richard A, Xiang Z, Brunel P, Pfeffer MA; ALTITUDE Investigators.

N Engl J Med. 2012 Dec 6;367(23):2204-13. doi: 10.1056/NEJMoa1208799. Epub 2012 Nov 3.

10.

Basal insulin and cardiovascular and other outcomes in dysglycemia.

ORIGIN Trial Investigators, Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):319-28. doi: 10.1056/NEJMoa1203858. Epub 2012 Jun 11.

11.

n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

ORIGIN Trial Investigators, Bosch J, Gerstein HC, Dagenais GR, Díaz R, Dyal L, Jung H, Maggiono AP, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):309-18. doi: 10.1056/NEJMoa1203859. Epub 2012 Jun 11.

12.

Purchase of antidepressant agents by patients with type 1 diabetes is associated with increased mortality rates in women but not in men.

Ahola AJ, Harjutsalo V, Saraheimo M, Forsblom C, Groop PH; FinnDiane Study Group.

Diabetologia. 2012 Jan;55(1):73-9. doi: 10.1007/s00125-011-2347-6. Epub 2011 Oct 28.

PMID:
22033620
13.

Novel susceptibility locus at 22q11 for diabetic nephropathy in type 1 diabetes.

Wessman M, Forsblom C, Kaunisto MA, Söderlund J, Ilonen J, Sallinen R, Hiekkalinna T, Parkkonen M, Maxwell AP, Tarnow L, Parving HH, Hadjadj S, Marre M, Peltonen L, Groop PH; FinnDiane Study Group.

PLoS One. 2011;6(9):e24053. doi: 10.1371/journal.pone.0024053. Epub 2011 Sep 1.

14.

Cumulative cost of prescription medication in outpatients with type 1 diabetes in Finland.

Lithovius R, Harjutsalo V, Forsblom C, Groop PH; FinnDiane Study Group.

Diabetologia. 2011 Mar;54(3):496-503. doi: 10.1007/s00125-010-1999-y. Epub 2010 Dec 7.

PMID:
21136035
15.

Depression is associated with the metabolic syndrome among patients with type 1 diabetes.

Ahola AJ, Thorn LM, Saraheimo M, Forsblom C, Groop PH; Finndiane Study Group.

Ann Med. 2010 Oct;42(7):495-501. doi: 10.3109/07853890.2010.503660.

PMID:
20653460
16.

DNA modifications by the omega-3 lipid peroxidation-derived mutagen 4-oxo-2-hexenal in vitro and their analysis in mouse and human DNA.

Kawai K, Chou PH, Matsuda T, Inoue M, Aaltonen K, Savela K, Takahashi Y, Nakamura H, Kimura T, Watanabe T, Sawa R, Dobashi K, Li YS, Kasai H.

Chem Res Toxicol. 2010 Mar 15;23(3):630-6. doi: 10.1021/tx9003819.

PMID:
20055452
17.

Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes.

Tolonen N, Forsblom C, Thorn L, Wadén J, Rosengård-Bärlund M, Saraheimo M, Feodoroff M, Mäkinen VP, Gordin D, Taskinen MR, Groop PH; FinnDiane Study Group.

Diabetologia. 2009 Dec;52(12):2522-30. doi: 10.1007/s00125-009-1541-2. Epub 2009 Oct 10.

PMID:
19816673
18.

Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes.

Mäkinen VP, Forsblom C, Thorn LM, Wadén J, Gordin D, Heikkilä O, Hietala K, Kyllönen L, Kytö J, Rosengård-Bärlund M, Saraheimo M, Tolonen N, Parkkonen M, Kaski K, Ala-Korpela M, Groop PH; FinnDiane Study Group.

Diabetes. 2008 Sep;57(9):2480-7. doi: 10.2337/db08-0332. Epub 2008 Jun 10.

19.

Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.

Saraheimo M, Forsblom C, Thorn L, Wadén J, Rosengård-Bärlund M, Heikkilä O, Hietala K, Gordin D, Frystyk J, Flyvbjerg A, Groop PH; FinnDiane Study Group.

Diabetes Care. 2008 Jun;31(6):1165-9. doi: 10.2337/dc07-2306. Epub 2008 Mar 17.

PMID:
18346990
20.

Analysis of 8-hydroxy-2'-deoxyguanosine in urine using high-performance liquid chromatography-electrospray tandem mass spectrometry.

Harri M, Kasai H, Mori T, Tornaeus J, Savela K, Peltonen K.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 15;853(1-2):242-6. Epub 2007 Mar 24.

PMID:
17442641

Supplemental Content

Loading ...
Support Center